Keurig Coffee Pod Recall: Decaf Products May Contain Caffeine
Keurig Coffee Pod Recall Over Caffeine Error

Keurig Dr Pepper has initiated a significant voluntary recall affecting its McCafé Premium Roast Decaf Coffee K-Cup Pods, following the discovery of a major labeling error. The company confirmed that products marketed as decaffeinated may, in fact, contain caffeine, prompting urgent action from both the manufacturer and regulatory authorities.

FDA Elevates Recall to Class II Risk Classification

Last week, the U.S. Food and Drug Administration (FDA) escalated the recall to a Class II risk classification. This designation indicates that consuming the affected pods could pose a temporary or medically reversible health risk. While the product remains safe for general consumption, individuals with caffeine sensitivity or specific health conditions are advised to exercise caution.

Identifying the Affected Products

The recall encompasses 960 cartons of coffee pods, each containing 84 individual K-Cup Pods. These were distributed across three U.S. states: California, Indiana, and Nevada. Consumers can identify the recalled items by checking for the following details:

  • Best-buy date: November 17, 2026
  • Batch number: 5101564894
  • Material number: 5000358463
  • ASIN: B07GCNDL91

It is not currently known whether Keurig Dr Pepper has received any customer complaints directly linked to this labeling error. However, the company is proactively managing the situation to ensure consumer safety.

Recommended Actions for Consumers

Customers who possess the recalled McCafé Premium Roast Decaf Coffee K-Cup Pods are strongly encouraged to take immediate steps. The FDA and Keurig Dr Pepper recommend either discarding the products or returning them to the original point of purchase. In return, consumers will be eligible for a full refund or a replacement product, ensuring they are not financially disadvantaged by the error.

Understanding Caffeine Consumption Guidelines

The FDA has provided clear guidance on safe caffeine intake levels for adults. According to the agency, consuming up to 400 milligrams of caffeine per day—equivalent to approximately two to three 12-fluid-ounce cups of coffee—is generally considered safe for most individuals without adverse effects. This recall highlights the importance of accurate labeling, particularly for those who monitor their caffeine intake for health reasons.

Similar Recall Incident Involving Gimme Coffee

This is not an isolated incident within the coffee industry. In October, Gimme Coffee, Inc. announced a voluntary recall for its Gimme! Decaf de Agua Coffee Pods due to an identical labeling error. These pods were also found to contain caffeine despite being labelled as decaffeinated.

Details of the Gimme Coffee Recall

The affected Gimme Coffee products include 252 boxes, each containing 10 coffee pods. These were distributed to multiple states, including Florida, Iowa, Massachusetts, Maryland, Missouri, North Carolina, New Jersey, New York, Ohio, and Wisconsin. Identification details for the recalled items are as follows:

  • UPC code: 051497457990
  • Outer packaging best-by date: October 15, 2025
  • Inner packaging best-by date: September 30

As of October 24, the company reported no customer complaints related to the mix-up. Consumers with the recalled Gimme Coffee pods are advised to contact the company directly or return the products to their place of purchase for a refund or replacement.

Contact Information for Gimme Coffee

Customers with questions or concerns regarding the Gimme Coffee recall can reach out to the company via phone at (607) 273-0111 or by email at orders@gimmecoffee.com. This provides a direct line for assistance and further clarification on the recall process.

Both recalls underscore the critical need for stringent quality control and accurate labeling in the food and beverage sector. Consumers are urged to remain vigilant, check their pantry items against the provided identification details, and follow the recommended actions to ensure their safety and well-being.